The Association for Creatine Deficiencies (ACD) is working with Geisinger, a National Institutes of Health (NIH) Clinical Genome Resource (ClinGen) grantee to share genetic and health information from patients affected by creatine deficiencies.
The American Society of Hematology (ASH) today announced a partnership with the University of North Carolina at Chapel Hill (UNC), a National Institutes of Health (NIH) Clinical Genome Resource (ClinGen) grantee, to develop a broad and accessible compendium of genomic data aimed at improving the diagnosis of some blood cancers and disorders.
GenomeWeb describes Heidi Rehm's update on ClinGen's strategies to resolve variant classifications conflicts in ClinVar at a US Food and Drug Administration public workshop this week focused on variant classification and interpretation efforts within precision oncology.
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.